Cai, M.; Yamamoto, G.; Hamaguchi, S.; Ueda, A.; Kawahara, R.; Motooka, D.; Takahashi, Y.; Kutsuna, S.
Cefiderocol Susceptibility in Japanese Clinical Enterobacterales Isolates and the Effect of IMP-Type Carbapenemases on Resistance. Antibiotics 2026, 15, 667.
https://doi.org/10.3390/antibiotics15070667
AMA Style
Cai M, Yamamoto G, Hamaguchi S, Ueda A, Kawahara R, Motooka D, Takahashi Y, Kutsuna S.
Cefiderocol Susceptibility in Japanese Clinical Enterobacterales Isolates and the Effect of IMP-Type Carbapenemases on Resistance. Antibiotics. 2026; 15(7):667.
https://doi.org/10.3390/antibiotics15070667
Chicago/Turabian Style
Cai, Manke, Go Yamamoto, Shigeto Hamaguchi, Akiko Ueda, Ryuji Kawahara, Daisuke Motooka, Yusuke Takahashi, and Satoshi Kutsuna.
2026. "Cefiderocol Susceptibility in Japanese Clinical Enterobacterales Isolates and the Effect of IMP-Type Carbapenemases on Resistance" Antibiotics 15, no. 7: 667.
https://doi.org/10.3390/antibiotics15070667
APA Style
Cai, M., Yamamoto, G., Hamaguchi, S., Ueda, A., Kawahara, R., Motooka, D., Takahashi, Y., & Kutsuna, S.
(2026). Cefiderocol Susceptibility in Japanese Clinical Enterobacterales Isolates and the Effect of IMP-Type Carbapenemases on Resistance. Antibiotics, 15(7), 667.
https://doi.org/10.3390/antibiotics15070667
